CIDPUSA.ORG Autoimmune

Ph Cancer diet,

God Our Guide

Main Links

Home page

Autoimmune Diseases Guide

Diet anti-inflammatory


Help page

Diagnosis page

Treatment Page

Turmeric Health page Link

It is interesting to note that cancer is virtually unknown among the Hopi Indians of Arizona and the Hunza of Northern Pakistan, so long as they stay in the same environment.  This strongly suggests that something they are consuming is protecting them from cancer.  The Hopi water is rich in Rubidium and potassium.  The Hunza water is rich in Cesium and potassium, making both of the water supplies rich with very caustically (alkaline) active metals.

In his publication, Cesium therapy in cancer patients, Dr. Sartori describes the 2 week treatment of 50 last stage, metastasized, terminal cancer patients  (13 comatose), with Cesium salts.  All were expected to die within weeks, with the survival rate being less than one in ten million.  After 2 weeks, 13 died with autopsies showing no presence of cancer.  After 12 months, 12 more had died, but 25, an astounding 50% survived.  

*Cesium has no natural radioactive form, and should not be confused with Cesium 137 which is artificially produced.

Cancer cells are very weak, far weaker than healthy cells.  It is very easy to kill cancer cells if you can create the right environment.  The following protocols are deadly to cancer cells, yet harmless if not outright beneficial to healthy cells.

Cesium Therapy in Cancer patients

H.E. Sartori

the Hopi Indian territory in Arizona, the Hunza area in North Pakistan, and the volcanic regions of Brazil.  The diet of these populations is similar to the nutritive requirements for the high Ph cancer therapy developed by Brewer's subsequent series of physical experiments with cancer cells. The introduction of such alkaline pH by these alkali salts may also neutralize the acidic and toxic material within the cancer cell.


Treatment was performed on 50 patients during the last  three years at Life Sciences Universal Medical Clinics in Rockville MD and in Washington D.C.  All patients were terminal subjects with generalized metastatic disease.  Forty-seven of the 50 patients studies had received maximal modalities of treatment, i.e., surgery, radiation, and various chemotherapy, before metabolic Cs-treatment was initiated.  Three patients were comatose and 14 of the patients were considered terminal due to previous treatments outcome and cancer complications.  The type of cancer of the patients studied and their number is detailed in table 1.

continue to next page